Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP924605.RAUB-_RTr5evAAG7UY0L7_Om3pqC8mQ66iR-MGeVlrRR4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP924605.RAUB-_RTr5evAAG7UY0L7_Om3pqC8mQ66iR-MGeVlrRR4130_assertion type Assertion NP924605.RAUB-_RTr5evAAG7UY0L7_Om3pqC8mQ66iR-MGeVlrRR4130_head.
- NP924605.RAUB-_RTr5evAAG7UY0L7_Om3pqC8mQ66iR-MGeVlrRR4130_assertion description "[Thus, targeting the downstream TGF-?/Smad3 signaling pathway by gene transfer of either Smad7 or Smad3-dependent microRNAs may represent a specific and effective therapeutic strategy for kidney disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924605.RAUB-_RTr5evAAG7UY0L7_Om3pqC8mQ66iR-MGeVlrRR4130_provenance.
- NP924605.RAUB-_RTr5evAAG7UY0L7_Om3pqC8mQ66iR-MGeVlrRR4130_assertion evidence source_evidence_literature NP924605.RAUB-_RTr5evAAG7UY0L7_Om3pqC8mQ66iR-MGeVlrRR4130_provenance.
- NP924605.RAUB-_RTr5evAAG7UY0L7_Om3pqC8mQ66iR-MGeVlrRR4130_assertion SIO_000772 21927575 NP924605.RAUB-_RTr5evAAG7UY0L7_Om3pqC8mQ66iR-MGeVlrRR4130_provenance.
- NP924605.RAUB-_RTr5evAAG7UY0L7_Om3pqC8mQ66iR-MGeVlrRR4130_assertion wasDerivedFrom befree-2016 NP924605.RAUB-_RTr5evAAG7UY0L7_Om3pqC8mQ66iR-MGeVlrRR4130_provenance.
- NP924605.RAUB-_RTr5evAAG7UY0L7_Om3pqC8mQ66iR-MGeVlrRR4130_assertion wasGeneratedBy ECO_0000203 NP924605.RAUB-_RTr5evAAG7UY0L7_Om3pqC8mQ66iR-MGeVlrRR4130_provenance.